Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects

Palbociclib is a good candidate for therapeutic drug monitoring (TDM) due to its narrow therapeutic range and frequency of toxicities, particularly high-grade neutropenia. In this prospective, bicentric clinical trial, we evaluated the palbociclib exposure–toxicity relationship and determined the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Leenhardt, Fanny, Fiteni, Frédéric, Gauthier, Ludovic, Alexandre, Marie, Guiu, Séverine, Firmin, Nelly, Pouderoux, Stéphane, Viala, Marie, Lossaint, Gerald, Gautier, Chloé, Mollevi, Caroline, Gracia, Matthieu, Gongora, Celine, Mbatchi, Litaty, Evrard, Alexandre, Jacot, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032884/
https://www.ncbi.nlm.nih.gov/pubmed/35456675
http://dx.doi.org/10.3390/pharmaceutics14040841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032884/
https://www.ncbi.nlm.nih.gov/pubmed/35456675
http://dx.doi.org/10.3390/pharmaceutics14040841

Ejemplares similares